Evidence map›Paper›PMID 39319165›Full record

ArticleHeliyon2024

Fibroblast growth factor 20 ameliorates cardiac hypertrophy via activation ErbB2.

Yunjie Chen, Xuan Zhou, Xu Wang, Yuanbin Zhang, Jiayi Song, Yan Cai, Yizhuo Zhao, Lin Mei, Suyan Zhu, Xueqin Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Signaling pathways regulating cardiac regeneration.Cell regeneration (London, England) · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yunjie ChenDepartment of Pharmacy, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Xuan ZhouDepartment of Pharmacy, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Xu WangSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325035, China.
Yuanbin ZhangDepartment of Pharmacy, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Jiayi SongReproductive Medicine Center, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Yan CaiDepartment of Clinical Pharmacy, Ningbo Ninth Hospital, Ningbo, 315020, Zhejiang, China.
Yizhuo ZhaoDepartment of Pharmacy, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Lin MeiDepartment of Pharmacy, Xiamen Medical College, Xiamen, 361000, Fujian, China.
Suyan ZhuDepartment of Pharmacy, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Xueqin ChenDepartment of Traditional Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factor 20 (FGF20) is a member of the fibroblast growth factor family and involved in embryonic development and cardiac repair. This study aimed to explore the role of FGF20 in cardiac hypertrophy and the underlying molecular mechanisms. FGF20 improved cardiac hypertrophy

Indexed as

ApoptosisCardiac hypertrophyErbB2FGF20Oxidative stress

Identifiers

PMID39319165
PMCPMC11419851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.